Allianz Asset Management
SYRE icon

Allianz Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Allianz Asset Management’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,800
Closed -$1.21M – 1744
2024
Q1 		$1.21M Buy
+31,800
New +$1.21M ﹤0.01% 1200